| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 116.89 | 0.00 (0.00%) | 58.53 - 131.82 | 1.8 million (Below Avg) |
Market data as of 4:00PM 06/19/13. Quotes are delayed by at least 15 min.
Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease
06/17/2013 1:30 AM ET
Oral Apremilast Achieves Statistical Significance for Primary and Secondary Endpoints in a Phase II Trial in Patients with Behçet’s Disease
06/14/2013 6:04 AM ET